(MedPage Today) — Fractures associated with androgen deprivation therapy (ADT) for metastatic prostate cancer decreased significantly in men who received a bisphosphonate in addition to standard of care (SOC), data from a large randomized trial…
Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/116646
Author :
Publish date : 2025-07-23 21:05:00
Copyright for syndicated content belongs to the linked Source.
